CN Stock MarketDetailed Quotes

300529 Jafron Biomedical

Watchlist
  • 32.99
  • +1.14+3.58%
Trading Nov 7 14:17 CST
26.35BMarket Cap32.76P/E (TTM)

Jafron Biomedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
47.76%2.2B
47.77%1.5B
30.00%744.34M
-22.84%1.92B
-26.64%1.49B
-34.88%1.01B
-17.90%572.56M
-6.88%2.49B
13.69%2.03B
30.80%1.55B
Operating revenue
47.76%2.2B
47.77%1.5B
30.00%744.34M
-22.84%1.92B
-26.64%1.49B
-34.88%1.01B
-17.90%572.56M
-6.88%2.49B
13.69%2.03B
30.80%1.55B
Other operating revenue
----
222.73%4.53M
----
-24.74%3.42M
----
29.57%1.4M
----
0.93%4.54M
----
-13.68%1.08M
Total operating cost
26.44%1.28B
22.05%861.39M
20.39%421.94M
-8.35%1.42B
-4.87%1.01B
-3.00%705.76M
11.51%350.49M
16.29%1.55B
29.75%1.07B
46.81%727.58M
Operating cost
42.80%410.33M
47.87%291.11M
41.52%158.66M
-12.75%383.98M
-15.14%287.35M
-21.85%196.86M
3.74%112.11M
9.46%440.11M
26.28%338.6M
43.93%251.89M
Operating tax surcharges
49.75%35.05M
52.64%23.97M
37.04%11.67M
-9.28%31.82M
-17.71%23.41M
-29.58%15.71M
-22.55%8.51M
-12.41%35.07M
6.97%28.45M
26.51%22.3M
Operating expense
15.69%510.26M
5.31%340.76M
1.00%158.5M
-12.08%615.97M
-4.46%441.05M
6.31%323.58M
26.13%156.94M
17.07%700.63M
26.14%461.66M
38.80%304.37M
Administration expense
14.25%128.71M
16.13%84.67M
39.32%38.47M
28.40%177.39M
22.60%112.65M
16.30%72.91M
-5.14%27.61M
5.48%138.15M
13.88%91.88M
34.02%62.69M
Financial expense
185.67%23M
145.20%8.1M
105.47%476.36K
-90.21%-33.9M
-57.89%-26.85M
-32.70%-17.91M
-1,009.28%-8.71M
-43.27%-17.82M
-6.02%-17M
5.41%-13.5M
-Interest expense (Financial expense)
19.00%47.95M
29.07%32.56M
33.49%16.35M
50.74%54.33M
171.94%40.29M
156.73%25.23M
151.53%12.25M
304.60%36.04M
246.51%14.82M
3,060.84%9.83M
-Interest Income (Financial expense)
60.99%-26.13M
43.46%-24.54M
27.08%-15.65M
-65.15%-87.96M
-77.87%-67M
-62.99%-43.41M
-247.18%-21.46M
-91.63%-53.26M
-84.07%-37.67M
-70.16%-26.63M
Research and development
-0.93%174.72M
-1.60%112.79M
0.27%54.17M
-3.36%245.38M
8.67%176.36M
14.82%114.62M
32.50%54.02M
46.12%253.91M
68.86%162.28M
95.09%99.82M
Credit Impairment Loss
-456.34%-8.73M
-299.36%-7.91M
-264.19%-1.28M
320.33%8.23M
130.26%2.45M
151.83%3.97M
115.65%777.07K
130.33%1.96M
-4.30%-8.09M
-52.12%-7.66M
Asset Impairment Loss
---15.32K
----
--0
-332.78%-28.18M
----
--0
--0
-11,345.79%-6.51M
--0
--0
Other net revenue
64.05%70.74M
29.01%42.75M
53.85%26.32M
-52.18%42.11M
-30.19%43.12M
-37.89%33.14M
59.40%17.11M
16.84%88.06M
15.11%61.76M
37.78%53.35M
Fair value change income
--334.75K
--5.8M
--1.01M
--0
--0
--0
--0
-200.00%-14.99K
---14.99K
---14.99K
Invest income
--24.69M
--8.18M
--2.53M
--0
--0
----
--0
-63.34%10.52M
-39.61%10.48M
-22.32%9.66M
Asset deal income
-59.89%2.37M
-64.28%2.16M
-76.75%1.28M
677.04%6.72M
1,039.72%5.92M
1,268.35%6.06M
2,659.55%5.5M
-12.01%864.77K
-7.14%519.06K
43.18%442.64K
Other revenue
49.84%52.08M
49.37%34.52M
110.20%22.78M
-31.87%55.35M
-40.97%34.76M
-54.62%23.11M
124.41%10.83M
55.69%81.24M
35.33%58.88M
64.18%50.93M
Operating profit
91.09%984.36M
99.39%676.98M
45.80%348.72M
-47.17%543.82M
-49.58%515.13M
-61.42%339.52M
-39.26%239.18M
-27.40%1.03B
0.75%1.02B
20.33%880.06M
Add:Non operating Income
-66.49%107.09K
-59.57%99.45K
-62.65%62.17K
-13.26%322.34K
56.21%319.56K
81.86%246.02K
288.79%166.45K
-51.91%371.63K
-70.00%204.58K
-74.35%135.28K
Less:Non operating expense
80.25%29.85M
57.22%16.83M
15.36%8.84M
77.61%23.12M
184.17%16.56M
256.16%10.71M
1,072.82%7.67M
13.41%13.02M
-4.07%5.83M
12.70%3.01M
Total profit
91.35%954.62M
100.65%660.25M
46.73%339.93M
-48.76%521.02M
-50.90%498.89M
-62.49%329.06M
-41.07%231.68M
-27.74%1.02B
0.73%1.02B
20.29%877.19M
Less:Income tax cost
111.33%165.79M
103.29%109.5M
53.74%56.01M
-29.86%95.3M
-46.58%78.45M
-58.94%53.86M
-38.01%36.43M
-35.72%135.86M
0.24%146.87M
19.06%131.18M
Net profit
87.62%788.83M
100.13%550.76M
45.42%283.93M
-51.67%425.72M
-51.62%420.44M
-63.11%275.2M
-41.61%195.25M
-26.33%880.95M
0.82%869.1M
20.51%746.01M
Net profit from continuing operation
87.62%788.83M
100.13%550.76M
45.42%283.93M
-51.67%425.72M
-51.62%420.44M
-63.11%275.2M
-41.61%195.25M
-26.33%880.95M
0.82%869.1M
20.51%746.01M
Less:Minority Profit
12.79%-2.81M
24.08%-1.75M
34.49%-837.96K
-24.94%-10.77M
25.96%-3.22M
-7.31%-2.31M
-56.54%-1.28M
-786.84%-8.62M
-325.93%-4.35M
-97.33%-2.15M
Net profit of parent company owners
86.86%791.63M
99.10%552.51M
44.90%284.77M
-50.93%436.49M
-51.50%423.66M
-62.91%277.51M
-41.37%196.53M
-25.67%889.56M
1.20%873.45M
20.64%748.16M
Earning per share
Basic earning per share
86.79%0.99
97.14%0.69
42.76%0.3512
-50.89%0.55
-51.82%0.53
-62.37%0.35
-41.43%0.246
-24.83%1.12
1.85%1.1
19.23%0.93
Diluted earning per share
86.54%0.97
100.00%0.68
44.00%0.3495
-49.56%0.57
-51.85%0.52
-63.44%0.34
-40.80%0.2427
-24.16%1.13
0.93%1.08
20.78%0.93
Other composite income
181.20%26.93M
-3,304.61%-33.17M
1.81M
1.81M
Other composite income of parent company owners
----
----
----
181.20%26.93M
----
----
----
-3,304.61%-33.17M
--1.81M
--1.81M
Total composite income
87.62%788.83M
100.13%550.76M
45.42%283.93M
-46.61%452.65M
-51.72%420.44M
-63.20%275.2M
-41.61%195.25M
-29.17%847.78M
1.03%870.91M
20.80%747.82M
Total composite income of parent company owners
86.86%791.63M
99.10%552.51M
44.90%284.77M
-45.89%463.42M
-51.60%423.66M
-63.00%277.51M
-41.37%196.53M
-28.51%856.4M
1.41%875.26M
20.93%749.97M
Total composite income of minority owners
12.79%-2.81M
24.08%-1.75M
34.49%-837.96K
-24.94%-10.77M
25.96%-3.22M
-7.31%-2.31M
-56.54%-1.28M
-786.84%-8.62M
-325.93%-4.35M
-97.33%-2.15M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Grant Thornton Certified Public Accountants (Special General Partnership)
--
--
--
Grant Thornton Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 47.76%2.2B47.77%1.5B30.00%744.34M-22.84%1.92B-26.64%1.49B-34.88%1.01B-17.90%572.56M-6.88%2.49B13.69%2.03B30.80%1.55B
Operating revenue 47.76%2.2B47.77%1.5B30.00%744.34M-22.84%1.92B-26.64%1.49B-34.88%1.01B-17.90%572.56M-6.88%2.49B13.69%2.03B30.80%1.55B
Other operating revenue ----222.73%4.53M-----24.74%3.42M----29.57%1.4M----0.93%4.54M-----13.68%1.08M
Total operating cost 26.44%1.28B22.05%861.39M20.39%421.94M-8.35%1.42B-4.87%1.01B-3.00%705.76M11.51%350.49M16.29%1.55B29.75%1.07B46.81%727.58M
Operating cost 42.80%410.33M47.87%291.11M41.52%158.66M-12.75%383.98M-15.14%287.35M-21.85%196.86M3.74%112.11M9.46%440.11M26.28%338.6M43.93%251.89M
Operating tax surcharges 49.75%35.05M52.64%23.97M37.04%11.67M-9.28%31.82M-17.71%23.41M-29.58%15.71M-22.55%8.51M-12.41%35.07M6.97%28.45M26.51%22.3M
Operating expense 15.69%510.26M5.31%340.76M1.00%158.5M-12.08%615.97M-4.46%441.05M6.31%323.58M26.13%156.94M17.07%700.63M26.14%461.66M38.80%304.37M
Administration expense 14.25%128.71M16.13%84.67M39.32%38.47M28.40%177.39M22.60%112.65M16.30%72.91M-5.14%27.61M5.48%138.15M13.88%91.88M34.02%62.69M
Financial expense 185.67%23M145.20%8.1M105.47%476.36K-90.21%-33.9M-57.89%-26.85M-32.70%-17.91M-1,009.28%-8.71M-43.27%-17.82M-6.02%-17M5.41%-13.5M
-Interest expense (Financial expense) 19.00%47.95M29.07%32.56M33.49%16.35M50.74%54.33M171.94%40.29M156.73%25.23M151.53%12.25M304.60%36.04M246.51%14.82M3,060.84%9.83M
-Interest Income (Financial expense) 60.99%-26.13M43.46%-24.54M27.08%-15.65M-65.15%-87.96M-77.87%-67M-62.99%-43.41M-247.18%-21.46M-91.63%-53.26M-84.07%-37.67M-70.16%-26.63M
Research and development -0.93%174.72M-1.60%112.79M0.27%54.17M-3.36%245.38M8.67%176.36M14.82%114.62M32.50%54.02M46.12%253.91M68.86%162.28M95.09%99.82M
Credit Impairment Loss -456.34%-8.73M-299.36%-7.91M-264.19%-1.28M320.33%8.23M130.26%2.45M151.83%3.97M115.65%777.07K130.33%1.96M-4.30%-8.09M-52.12%-7.66M
Asset Impairment Loss ---15.32K------0-332.78%-28.18M------0--0-11,345.79%-6.51M--0--0
Other net revenue 64.05%70.74M29.01%42.75M53.85%26.32M-52.18%42.11M-30.19%43.12M-37.89%33.14M59.40%17.11M16.84%88.06M15.11%61.76M37.78%53.35M
Fair value change income --334.75K--5.8M--1.01M--0--0--0--0-200.00%-14.99K---14.99K---14.99K
Invest income --24.69M--8.18M--2.53M--0--0------0-63.34%10.52M-39.61%10.48M-22.32%9.66M
Asset deal income -59.89%2.37M-64.28%2.16M-76.75%1.28M677.04%6.72M1,039.72%5.92M1,268.35%6.06M2,659.55%5.5M-12.01%864.77K-7.14%519.06K43.18%442.64K
Other revenue 49.84%52.08M49.37%34.52M110.20%22.78M-31.87%55.35M-40.97%34.76M-54.62%23.11M124.41%10.83M55.69%81.24M35.33%58.88M64.18%50.93M
Operating profit 91.09%984.36M99.39%676.98M45.80%348.72M-47.17%543.82M-49.58%515.13M-61.42%339.52M-39.26%239.18M-27.40%1.03B0.75%1.02B20.33%880.06M
Add:Non operating Income -66.49%107.09K-59.57%99.45K-62.65%62.17K-13.26%322.34K56.21%319.56K81.86%246.02K288.79%166.45K-51.91%371.63K-70.00%204.58K-74.35%135.28K
Less:Non operating expense 80.25%29.85M57.22%16.83M15.36%8.84M77.61%23.12M184.17%16.56M256.16%10.71M1,072.82%7.67M13.41%13.02M-4.07%5.83M12.70%3.01M
Total profit 91.35%954.62M100.65%660.25M46.73%339.93M-48.76%521.02M-50.90%498.89M-62.49%329.06M-41.07%231.68M-27.74%1.02B0.73%1.02B20.29%877.19M
Less:Income tax cost 111.33%165.79M103.29%109.5M53.74%56.01M-29.86%95.3M-46.58%78.45M-58.94%53.86M-38.01%36.43M-35.72%135.86M0.24%146.87M19.06%131.18M
Net profit 87.62%788.83M100.13%550.76M45.42%283.93M-51.67%425.72M-51.62%420.44M-63.11%275.2M-41.61%195.25M-26.33%880.95M0.82%869.1M20.51%746.01M
Net profit from continuing operation 87.62%788.83M100.13%550.76M45.42%283.93M-51.67%425.72M-51.62%420.44M-63.11%275.2M-41.61%195.25M-26.33%880.95M0.82%869.1M20.51%746.01M
Less:Minority Profit 12.79%-2.81M24.08%-1.75M34.49%-837.96K-24.94%-10.77M25.96%-3.22M-7.31%-2.31M-56.54%-1.28M-786.84%-8.62M-325.93%-4.35M-97.33%-2.15M
Net profit of parent company owners 86.86%791.63M99.10%552.51M44.90%284.77M-50.93%436.49M-51.50%423.66M-62.91%277.51M-41.37%196.53M-25.67%889.56M1.20%873.45M20.64%748.16M
Earning per share
Basic earning per share 86.79%0.9997.14%0.6942.76%0.3512-50.89%0.55-51.82%0.53-62.37%0.35-41.43%0.246-24.83%1.121.85%1.119.23%0.93
Diluted earning per share 86.54%0.97100.00%0.6844.00%0.3495-49.56%0.57-51.85%0.52-63.44%0.34-40.80%0.2427-24.16%1.130.93%1.0820.78%0.93
Other composite income 181.20%26.93M-3,304.61%-33.17M1.81M1.81M
Other composite income of parent company owners ------------181.20%26.93M-------------3,304.61%-33.17M--1.81M--1.81M
Total composite income 87.62%788.83M100.13%550.76M45.42%283.93M-46.61%452.65M-51.72%420.44M-63.20%275.2M-41.61%195.25M-29.17%847.78M1.03%870.91M20.80%747.82M
Total composite income of parent company owners 86.86%791.63M99.10%552.51M44.90%284.77M-45.89%463.42M-51.60%423.66M-63.00%277.51M-41.37%196.53M-28.51%856.4M1.41%875.26M20.93%749.97M
Total composite income of minority owners 12.79%-2.81M24.08%-1.75M34.49%-837.96K-24.94%-10.77M25.96%-3.22M-7.31%-2.31M-56.54%-1.28M-786.84%-8.62M-325.93%-4.35M-97.33%-2.15M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Grant Thornton Certified Public Accountants (Special General Partnership)------Grant Thornton Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data